Home > News > UNeMed and Telomolecular Sign License for Nanoparticle Use
January 31st, 2006
UNeMed and Telomolecular Sign License for Nanoparticle Use
Abstract:
Telomolecular Corp., a biotechnology company, that develops biopharmaceutical therapies designed to treat aging and age-related disease, today announced the signing of a global licensing agreement with UNeMed, Omaha Nebraska, the licensing agent for the University of Nebraska Medical Center, a leading licensor of advanced medical and biomedical products and patents.
Source:
prweb
Related News Press |
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||